Resveratrol at 400 mg/kg daily completely reversed triclosan-induced colonic damage in chickens, restoring tight junction proteins, reducing inflammatory markers d-lactate and DAO, and normalizing mitochondrial function through the SIRT1/PGC-1α pathway. The study demonstrates resveratrol's ability to counteract damage from triclosan, a ubiquitous antimicrobial found in soaps, toothpastes, and personal care products. This finding carries significant implications for human health, as triclosan exposure is virtually universal and has been linked to gut microbiome disruption and metabolic disorders. The mechanism involving SIRT1 activation—a key longevity pathway—suggests resveratrol's protective effects extend beyond simple antioxidant activity to fundamental cellular repair processes. While conducted in chickens, the dosage translates to roughly 1-2 grams daily for humans, achievable through supplementation. The research addresses a critical gap in understanding how to mitigate environmental toxin exposure that's largely unavoidable in modern life. However, the animal model and relatively short exposure period limit immediate clinical application. This represents confirmatory evidence for resveratrol's protective mechanisms while highlighting an underappreciated threat from everyday chemical exposure.